News | March 28, 2022
Aurobindo enters domestic formulations space with the acquisition of Veritaz for Rs 171 Cr
Veritaz has over 40 brands marketed across the acute and critical care therapeutic segments
Veritaz has over 40 brands marketed across the acute and critical care therapeutic segments
These courses are for pre-selected candidates who have completed their MBBS with an additional 2 years of surgical experience training
The TAT-5000 and the TAT-2000 thermometers for professional use by doctors and nurses and the TAT-2000C thermometer for consumer applications are based on a very innovative infrared technology
Study to evaluate effectiveness of hypoglossal nerve stimulation
Fiscal support in line with what is available in key innovation hubs such as USA and China will drive the next leg of drug discovery in India
Health experts of the country have pointed out that the benefits of the drug outweigh the potential risks it may have in the case of high-risk patients
The R&D centre will endeavour to bring scientifically advanced biological, biotechnology products and novel drug delivery systems
The Home Healthcare market is expected to be US $ 14.2 by 2025
Patient with acute Covid-19 infection treated at BGS Gleneagles Global Hospital
2022 is going to be the year of opportunities and innovations from the medical industry in India
Subscribe To Our Newsletter & Stay Updated
